The basic principle in the Biocidal Products Regulation ((EU) No 528/2012 (BPR)) is that a biocidal product (BP) must be authorised before it can be made available on the market or used in the European Union (EU)/ European Economic Area (EEA).
This takes place in two consecutive steps. As the first step, the active substance is evaluated and, provided the criteria are fulfilled, is then approved in a specified product-type (PT). The second step is the authorisation of each BP consisting of, containing or generating the approved active substance(s).
This document concerns the first step, approval of active substances.
October 2016
Collegati
| Descrizione | Lingua | Dimensioni | Downloads | |
|---|---|---|---|---|
 |
Abbonati Chemicals
|
EN | 5803 kB | 3 |
della Commissione del 5 luglio 2021 che modifica gli allegati II e III del regolamento (CE) n. 1223/2009 del Parlamento europeo e del Consiglio sui prodotti cosmetici
GU L 23...
ID 20813 | 21.11.2023
Forum project report: Harmonised enforcement project on biocidal products with approved/non-approved active substances
Helsinki...
Regolamento (CE) n. 1451/2007 della Commissione, del 4 dicembre 2007 , concernente la seconda fase del programma di lavoro decennale di cui all’articolo 16, paragrafo 2, d...
Testata editoriale iscritta al n. 22/2024 del registro periodici della cancelleria del Tribunale di Perugia in data 19.11.2024